Yokogawa Electric's life science business provides a range of solutions to support people's lives and protect health and safety. In addition to our business in the pharmaceutical and healthcare sectors, we also engage in ensuring that everyone has access to safe food and drinking water. In order to improve the productivity of the pharmaceutical and food benefit chains, we utilize the sensing and control technology developed by Yokogawa Electric over the years to support innovation in products and production processes. In the water treatment industry, our goal is to create new benefits by utilizing measurement techniques obtained in activities such as genomic analysis and scientific instruments.

Business Overview

Strategic direction and business areas

• strategic direction
  Our life science business focuses on the pharmaceutical, healthcare, food, and water treatment industries, aiming to enhance well-being. Our business vision is: 'We will advance the self-reliance of the biotechnology industry (BIA) and contribute to embracing a harmonious future.'. ”After implementing BIA, the workload is reduced, allowing researchers and operators to focus on higher-level research and production site optimization. By leveraging Yokogawa Electric's advantages in measurement, imaging, analysis, diagnosis, integration, and connectivity, we provide our customers with feasible solutions to help them acquire new knowledge and innovate.

• business domain
  Our business covers the entire benefit chain of the pharmaceutical, healthcare, food&beverage, and water treatment industries, from research, development, production to logistics and services.

Contribute to the Sustainable Development Goals

Based on the social vision of 2050, Yokogawa Electric is striving to achieve its "three goals" for sustainable development. One of our goals is to ensure happiness and health. For this reason, our life science business focuses on the pharmaceutical, healthcare, water treatment, and food industries. Many of our products have been used in the research of vaccines and therapeutic drugs. We will continue to expand our life science business activities directly related to issues such as aging, resource depletion, and food and water scarcity.

Contribution areas of life science business towards 2030 and related sustainable development goals